Lactate-to-Albumin Ratio Predicts 30-Day Mortality in Sepsis Patients

Overview

This retrospective cohort study of 1,205 sepsis patients demonstrates that the lactate-to-albumin ratio (LAR) is a significant predictor of 30-day mortality. LAR showed superior prognostic accuracy compared to lactate or albumin alone, supporting its use as a reliable early risk stratification marker in sepsis management.

Background

Sepsis is a life-threatening condition characterized by systemic inflammation and organ dysfunction, with high global morbidity and mortality rates. Early identification of prognostic markers is critical to guide timely interventions and improve outcomes. Lactate is a common marker of tissue hypoxia but can be influenced by various factors, while albumin reflects nutritional and inflammatory status. The lactate-to-albumin ratio (LAR) has emerged as a composite indicator with potential prognostic value in critical illnesses, but its role in sepsis mortality prediction remains unclear.

Data Highlights

Key Findings

• The lactate-to-albumin ratio (LAR) was significantly higher in non-survivors compared to survivors among sepsis patients.
• LAR demonstrated better predictive accuracy for 30-day mortality than lactate or albumin alone, as evidenced by ROC curve analysis.
• Logistic regression confirmed LAR as an independent predictor of 30-day mortality after adjusting for confounders.
• Subgroup analyses indicated that the prognostic value of LAR was consistent across different patient demographics and clinical parameters.
• Interaction analysis revealed that the combined effect of lactate and albumin levels on mortality risk was better captured by LAR.

Clinical Implications

The lactate-to-albumin ratio can serve as a simple, readily available biomarker to enhance early risk stratification in sepsis patients. Incorporating LAR into clinical assessment may facilitate timely, targeted interventions such as prompt antibiotic administration and hemodynamic support, potentially improving survival outcomes. Clinicians should consider LAR alongside traditional markers to better identify high-risk patients.

Conclusion

This study establishes the lactate-to-albumin ratio as a valuable prognostic tool for predicting 30-day mortality in sepsis patients. Its superior predictive performance supports its integration into routine clinical evaluation to optimize sepsis management.

References

1. Wang et al. 2023 -- Assessing the Lactate-to-Albumin Ratio as a Predictor of 30-Day Mortality in Patients with Sepsis